Log in

NYSE:STESteris Stock Price, Forecast & News

$138.72
-0.83 (-0.59 %)
(As of 04/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$137.57
Now: $138.72
$140.94
50-Day Range
$107.76
MA: $147.73
$168.51
52-Week Range
$105.69
Now: $138.72
$168.98
Volume907,132 shs
Average Volume906,096 shs
Market Capitalization$11.76 billion
P/E Ratio30.16
Dividend Yield1.06%
Beta0.86
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.
Read More
Steris logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.1Dividend Strength: 5.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.05 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.78 billion
Cash Flow$7.56 per share
Book Value$37.66 per share

Profitability

Net Income$304.05 million

Miscellaneous

Employees12,000
Market Cap$11.76 billion
Next Earnings Date5/11/2020 (Estimated)
OptionableOptionable

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.


Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock been impacted by COVID-19 (Coronavirus)?

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, STE shares have decreased by 4.5% and is now trading at $138.72. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Steris?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Steris.

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Steris.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) released its quarterly earnings results on Monday, February, 10th. The medical equipment provider reported $1.45 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.42 by $0.03. The medical equipment provider earned $774.30 million during the quarter, compared to the consensus estimate of $748.45 million. Steris had a net margin of 13.21% and a return on equity of 16.33%. The company's revenue was up 11.2% compared to the same quarter last year. During the same quarter last year, the firm earned $1.26 earnings per share. View Steris' earnings history.

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Monday, February 10th. Stockholders of record on Tuesday, February 25th will be paid a dividend of $0.37 per share on Thursday, March 26th. This represents a $1.48 annualized dividend and a yield of 1.07%. The ex-dividend date is Monday, February 24th. View Steris' dividend history.

What guidance has Steris issued on next quarter's earnings?

Steris updated its FY 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided EPS guidance of 5.65-5.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.57.

What price target have analysts set for STE?

4 brokerages have issued 1 year target prices for Steris' shares. Their forecasts range from $138.00 to $150.00. On average, they expect Steris' stock price to reach $144.33 in the next year. This suggests a possible upside of 4.0% from the stock's current price. View analysts' price targets for Steris.

Has Steris been receiving favorable news coverage?

Media coverage about STE stock has been trending very negative on Sunday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Steris earned a news impact score of -3.3 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutSteris.

Are investors shorting Steris?

Steris saw a drop in short interest during the month of March. As of March 13th, there was short interest totaling 1,275,100 shares, a drop of 18.8% from the February 27th total of 1,570,000 shares. Based on an average daily volume of 881,000 shares, the short-interest ratio is presently 1.4 days. Approximately 1.5% of the shares of the company are sold short. View Steris' Current Options Chain.

Who are some of Steris' key competitors?

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Mastercard (MA), AbbVie (ABBV), Mcdonald's (MCD), Gilead Sciences (GILD), Pfizer (PFE), Stryker (SYK), AT&T (T), Zimmer Biomet (ZBH) and Zoetis (ZTS).

Who are Steris' key executives?

Steris' management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
  • Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are Steris' major shareholders?

Steris' stock is owned by a number of retail and institutional investors. Top institutional investors include Deane Retirement Strategies Inc. (0.01%), Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%) and Fulton Bank N.A. (0.00%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View institutional ownership trends for Steris.

Which institutional investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Fulton Bank N.A.. Company insiders that have sold Steris company stock in the last year include Cary L Majors, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, and Walter M Rosebrough Jr. View insider buying and selling activity for Steris.

Which institutional investors are buying Steris stock?

STE stock was bought by a variety of institutional investors in the last quarter, including Deane Retirement Strategies Inc., and Nelson Van Denburg & Campbell Wealth Management Group LLC. View insider buying and selling activity for Steris.

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $138.72.

How big of a company is Steris?

Steris has a market capitalization of $11.76 billion and generates $2.78 billion in revenue each year. The medical equipment provider earns $304.05 million in net income (profit) each year or $4.89 on an earnings per share basis. Steris employs 12,000 workers across the globe. View additional information about Steris.

What is Steris' official website?

The official website for Steris is http://www.steris.com/.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: What is a short straddle?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel